1. Clinical & Scientific Overview
Calcium Citrate / Calcium Citrate Malate (CCM) (TIP-MED-000190, Reference Code [10.6]) is classified under
Vitamins, Minerals & Nutritional Supplements (Ch 10) as a Organic Acid-Independent Soluble Calcium Salt (~21–24% Elemental Calcium; Urinary Citrate Inhibitor of Renal Calculi).
Within the Indian regulatory and compendial framework, it is governed under Non-Schedule / OTC or Schedule K Permitted Preparation (Medical Supervision Recommended for High-Dose/Therapeutic Regimens).
Representative Indian Market Examples (Edition 2.7 Ch 10 [10.6], p. 129): Calcitrate, CCM (GSK/Haleon), Milical, Citracal, Shelcal-CT / Ostoshine-CCM, Caldikind — Strengths & Dosage Forms: Oral Film-Coated Tablets: Calcium Citrate 1000–1200 mg or Calcium Citrate Malate (CCM) delivering 250 mg to 500 mg Elemental Calcium (+ Vitamin D3 250–1000 IU, Magnesium, Zinc)
Oral Film-Coated Tablets: Calcium Citrate 1000–1200 mg or Calcium Citrate Malate (CCM) delivering 250 mg to 500 mg Elemental Calcium (+ Vitamin D3 250–1000 IU, Magnesium, Zinc)
3. Mechanism of Action & Pharmacodynamics
Organic Acid-Independent Soluble Calcium Salt (~21–24% Elemental Calcium; Urinary Citrate Inhibitor of Renal Calculi) acting on target receptor/enzyme pathways in Vitamins, Minerals & Nutritional Supplements (Ch 10): clinical efficacy is mediated via Organic Acid-Independent Soluble Calcium Salt (~21–24% Elemental Calcium; Urinary Citrate Inhibitor of Renal Calculi) for Calcium supplementation in elderly patients with age-related achlorhydria, patients on chronic Proton Pump Inhibitors (Pantoprazole/Omeprazole) or H2-blockers, patients with chronic constipation, and patients with a history of renal calculi (kidney stones)..
4. Therapeutic Indications & Evidence-Supported Uses
- Calcium supplementation in elderly patients with age-related achlorhydria, patients on chronic Proton Pump Inhibitors (Pantoprazole/Omeprazole) or H2-blockers, patients with chronic constipation, and patients with a history of renal calculi (kidney stones)
🇮🇳 Jurisdiction & Indication Note: Indications and schedules reflect Indian compendial and regulatory records (CDSCO / Indian Pharmacopoeia & NFI / NLEM 2022). Where international reference labels (US FDA DailyMed / NCBI StatPearls) are cited for pharmacokinetic or mechanistic parameters, international approvals do not automatically imply CDSCO approval in India.
5. Educational Dosage Context, Formulations & Administration
Educational Dosing & Regimen Summary: General Adult Reference: 250 mg to 500 mg elemental calcium once or twice daily. Follow physician prescription.
Administration & Meal Timing: May be taken WITH or WITHOUT food! (Unlike Calcium Carbonate, Calcium Citrate and CCM are water-soluble and do NOT require gastric acid for intestinal absorption!). | Once or twice daily (typically after lunch and/or dinner, spaced ≥4 hours away from morning Levothyroxine and ≥2 hours from Iron/Antibiotics).
6. Pharmacokinetics, Metabolism & Renal/Hepatic Adjustment
Absorption, distribution, metabolism, and excretion follow class pharmacokinetic profile; verify patient renal/hepatic function.
Renal: Citrate is metabolised to bicarbonate and increases urinary citrate excretion (which naturally inhibits calcium oxalate stone crystallization in the urine!); however, in advanced CKD (Stages 4–5), avoid combining with aluminium salts and note that calcium citrate is less effective as a phosphate binder than calcium carbonate. Hepatic: Safe.
Renal: Citrate is metabolised to bicarbonate and increases urinary citrate excretion (which naturally inhibits calcium oxalate stone crystallization in the urine!); however, in advanced CKD (Stages 4–5), avoid combining with aluminium salts and note that calcium citrate is less effective as a phosphate binder than calcium carbonate. Hepatic: Safe.
Renal: Citrate is metabolised to bicarbonate and increases urinary citrate excretion (which naturally inhibits calcium oxalate stone crystallization in the urine!); however, in advanced CKD (Stages 4–5), avoid combining with aluminium salts and note that calcium citrate is less effective as a phosphate binder than calcium carbonate. Hepatic: Safe.
7. Contraindications, Precautions & High-Risk Warnings
- Contraindicated in hypercalcaemia and severe hypercalciuria. CRITICAL CKD ALUMINIUM INTERACTION: Citrate salts markedly increase the intestinal absorption of Aluminium! Never co-administer Calcium Citrate with Aluminium-containing antacids (Digene/Gelusil) or Sucralfate in patients with Chronic Kidney Disease (precipitates acute aluminium neurotoxicity/encephalopathy and osteomalacia!).
Key Clinical Precautions: Renal: Citrate is metabolised to bicarbonate and increases urinary citrate excretion (which naturally inhibits calcium oxalate stone crystallization in the urine!); however, in advanced CKD (Stages 4–5), avoid combining with aluminium salts and note that calcium citrate is less effective as a phosphate binder than calcium carbonate. Hepatic: Safe.
8. Adverse Effects Profile
- Very well tolerated; significantly lower rates of constipation, abdominal bloating, and flatulence than Calcium Carbonate (because no CO2 gas is generated in the stomach!).
- Hypercalcaemia (if combined with excessive Vitamin D/thiazides), aluminium toxicity if combined with Al-antacids in CKD.
- Monitor for severe hypersensitivity, organ toxicity, or dose-limiting adverse events.
9. Major Drug–Drug, Drug–Food & Drug–Herb Interactions
- Same chelation interactions as Calcium Carbonate with Levothyroxine (space ≥4 hours), Fluoroquinolones, Tetracyclines, Oral Iron, and Bisphosphonates (space ≥2–4 hours)! Enhances intestinal Aluminium absorption from antacids/sucralfate
- Safe and fully absorbed alongside PPIs (Pantoprazole/Rabeprazole)
10. Clinical Monitoring, Patient Counselling & Storage
Clinical & Laboratory Monitoring: Monitor clinical response, baseline renal/hepatic parameters, and relevant serum biomarkers.
Pharmacist Patient Counselling Points:
- Patient Counselling Checklist: Explain to elderly patients who complain of severe constipation or gas from standard Calcium Carbonate (Shelcal), or who take daily acidity capsules (Pantoprazole), that Calcium Citrate / CCM absorbs smoothly without needing stomach acid, does not produce stomach gas, and helps protect against kidney stones.
- Meal & Clock Timing Instruction: May be taken WITH or WITHOUT food! (Unlike Calcium Carbonate, Calcium Citrate and CCM are water-soluble and do NOT require gastric acid for intestinal absorption!). (Once or twice daily (typically after lunch and/or dinner, spaced ≥4 hours away from morning Levothyroxine and ≥2 hours from Iron/Antibiotics).)
- Missed Dose Protocol: Take as soon as remembered (keeping ≥2–4 hours from interacting medications); do not double.
- Geriatric Dispensing Pearl: Preferred calcium formulation for elderly CGHS beneficiaries due to high prevalence of gastric hypochlorhydria, concurrent PPI therapy, and chronic constipation.
Storage, Stability & Dispensing Safeguards: Store below 25°C–30°C in original moisture- and light-resistant packaging out of reach of children. Available forms: Oral Film-Coated Tablets: Calcium Citrate 1000–1200 mg or Calcium Citrate Malate (CCM) delivering 250 mg to 500 mg Elemental Calcium (+ Vitamin D3 250–1000 IU, Magnesium, Zinc)
11. Visual Pharmacology & Mechanism Diagram (svg-v339-01-adme-12-step-journey)
12. Authoritative References, Regulatory Sources & Editorial Disclaimer
Primary Compendial & Guideline Reference: Indian Pharmacist Desk Reference — Professional Edition 2.7 (2026–27) • Ch 10 [10.6] (p. 129)
Official Verification Portals: Indian Pharmacopoeia Commission (IPC) & National Formulary of India (NFI) • Central Drugs Standard Control Organization (CDSCO) • Ministry of Health & Family Welfare — NLEM 2022 • NCBI Bookshelf / StatPearls Pharmacology Reference • DailyMed (US FDA Official Prescribing Reference)
Last Medically & Pharmaceutically Reviewed: 2026-11-10 • Verification Status: HANDBOOK_SOURCE_CONTENT
Educational & Clinical Disclaimer: This reference profile is published solely for pharmacy education, academic study, and professional clinical reference. It does not substitute for patient-specific clinical judgement, qualified specialist oncology/medical supervision, or official CDSCO/IP prescribing information. Never self-medicate with prescription, Schedule H/H1/X, NDPS, or oncology medicines.
13. Related Reference Monographs, Educational Guides & Visual Concept
💊 Related Pharmacological / Category Profiles
- [10.17]-C124 Coenzyme Q10 (Ubidecarenone) — Mitochondrial Metabolic Coenzymes & Neuropathic/Myopathic Antioxi
- [10.17]-C125 L-Carnitine — Mitochondrial Metabolic Coenzymes & Neuropathic/Myopathic Antioxi
- [10.1] Vitamin B12 (Methylcobalamin / Mecobalamin & Cyanocobalamin) — Water-Soluble Neurotropic & Haematinic Vitamin (Cobalamin; Coenzy
- [10.2] Vitamin D3 (Cholecalciferol — including 60,000 IU High-Strength Preparations) — Fat-Soluble Secosteroid Prohormone (Converted Hepatically to 25(O